tirzepatide risk of cancer BREAKING NEWS 🚨 A new study from the University Michigan found that SHRINKS BREAST TUMORS IN MICE. For women 40–55, this matters. Weight gain and breast cancer both Key Takeaways Patients taking GLP-1

By activating GIP and GLP-1 receptors, tirzepatide enhances insulin secretion in response to meals, suppresses glucagon release (which reduces hepatic glucose production), slows gastric emptying, and promotes satiety through central appetite regulation

Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial

Unlike traditional single-pathway or dual-pathway incretin compounds, this molecule is structurally designed to activate GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously

Eating these vegetables raw or lightly steamed is often better than boiling them

Skura, a board-certified physician, is dedicated to helping Chicago patients achieve optimal health through a personalized approach to wellness

Notably, no cases of clinically significant hypoglycemia, medullary thyroid cancer, or C-cell hyperplasia were reported in published trial data